Health Canada has approved the first generic version of Ozempic, the brand-name diabetes drug made by Danish pharmaceutical company Novo Nordisk.
The department said in a news release that it authorized a generic semaglutide injection submitted by Dr. Reddy’s Laboratories after reviewing evidence showing the product met Health Canada’s requirements for safety, efficacy, and quality for generic drugs.
